Code Changes for DMEPOS Require Action

  • By
  • In Billing
  • December 3, 2024
  • Comments Off on Code Changes for DMEPOS Require Action
Code Changes for DMEPOS Require Action

Time to update your chargemaster with the HCPCS Level II code update for fiscal year 2025.

The fiscal year (FY) 2025 update to the HCPCS Level II code set, used to report durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS), adds 169 new codes, revises 56 code descriptors, and deletes 63 codes. Here’s an overview of the code changes made by the Centers for Medicare & Medicaid Services (CMS) that are effective Jan. 1, 2025.

Code Changes by Section

There’s just one new code added to the Transportation Services section of HCPCS:

A9615 Injection, pegulicianine, 1 mg

This code for LUMISIGHT replaces discontinued code C9171. There are another 10 codes deleted in the Outpatient Prospective Payment System (OPPS) section of HCPCS — four of which are replaced with new J codes (now that the drugs they represent are FDA approved):

Discontinued            Added

C9169                         J9028
C9170                         J9026
C9172                         J1414
C9290                         J0666

You’ll find an additional 14 new C codes for various OPPS services and supplies in the FY 2025 update.

In the Durable Medical Equipment section of HCPCS, there are 12 new E codes (E1803-E1829) for dynamic adjustable elbow extension only devices, including soft interface material. These codes were added to resolve an edit problem that was preventing providers from billing for both extension and flexion devices on the same claim. The parent code for each device is revised to indicate the possible use of both devices instead of either/or. The existing dynamic adjustable extension and flexion device codes are also revised to read the same as the new codes.

HCPCS Level II G codes represent either professional healthcare procedures and services that would otherwise be coded in CPT® but for which there are no CPT® codes, or services that may be reported by providers participating in incentive programs such as the Quality Payment Program. There are 34 new G codes (G0532-G0565) for FY 2025, including codes for interprofessional telephone/internet/electronic health record assessment and management services (G0546-G0551) and advanced primary care management services (G0556-G0558). There are also 33 codes being removed from this section and 26 codes with long description changes.

In the Alcohol and Drug abuse Treatment section, two new H codes identify behavioral health and clinical care services for American Indian and Alaska Native Tribal members, or other ethnicities, “affected by an unacknowledged death or missing indigenous or other person and for care related to HT for American Indians and Alaska Natives,” the code applicant states in CMS’s 2024 HCPCS Application Summary. The codes are:

H0052 Missing and murdered indigenous persons (mmip) mental health and clinical care

H0053 Historical trauma (ht) mental health and clinical care for indigenous persons

There are 25 new J codes for drugs and biologicals, including the four listed above and J7514 Mycophenolate mofetil (myhibbin), oral suspension, 100 mg, an antimetabolite immunosuppressant indicated in adult and pediatric patients aged 3 months and older for the prophylaxis of organ rejection of allogeneic kidney, heart, or liver transplants, according to the code applicant’s summary. There are also three long description and two short description code revisions in this section.

In the Medical Services section of HCPCS, there are 55 new M codes (M1371-M1425), five discontinued codes, and 20 codes with long descriptor changes.

There are also 21 new temporary codes for various products, including Q5139 Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg for treatment of patients with paroxysmal nocturnal hemoglobinuria to reduce hemolysis and patients with atypical hemolytic uremic syndrome to inhibit complement-mediated thrombotic microangiopathy, according to the code applicant’s summary. The FY 2025 update also discontinues seven Q codes in this section.

Lastly, modifier JG Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes is discontinued.

Payment Changes

There are just two HCPCS Level II codes with payment changes:

A4954 Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each

E0491 Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by hardware remote, 90-day supply

The above changes are just some of the highlights in the FY 2025 code update. Visit the CMS.gov website for the complete and official update of the HCPCS Level II code system.


Source:

https://www.cms.gov/medicare/coding-billing/healthcare-common-procedure-system/quarterly-update; Nov. 4, 2024

Renee Dustman
Follow me

medical coding books

About Has 1024 Posts

Renee Dustman, BS, AAPC MACRA Proficient, is managing editor - content & editorial at AAPC. She holds a Bachelor of Science degree in Media Communications - Journalism. Renee has more than 30 years' experience in journalistic reporting, print production, graphic design, and content management. Follow her on Twitter @dustman_aapc.

Comments are closed.